username: password:     Join free | Forgot password
Add to favorites    中文
home > news and events
2013 BIO Convention in China to Provide Global Look at China鈥檚 Growing Biotech Sector

Clicks:354 Date:11/13/13
Event brings Western and Chinese life science companies together for partnering and deal making

BIO Convention in China 2013:Biotechnology Industry Organization (BIO)
BIO Convention in China 2013
BEIJING--()--Executives from biotech and pharmaceutical companies, along with investment firms from North America, Europe and Asia, will convene today for the 3rd annual BIO Convention in China, where they will meet and explore business opportunities with China鈥檚 emerging biotech sector. Hosted by the Biotechnology Industry Organization (BIO), the program will begin Tuesday, Nov. 12th and continue through Wednesday, Nov. 13th at the China National Convention Center in Beijing, China.

鈥淐hina鈥檚 biotech sector is growing at a steady pace, with double digit growth in sales revenues and profits鈥

"China鈥檚 biotech sector is growing at a steady pace, with double digit growth in sales revenues and profits," said BIO President and CEO Jim Greenwood. "BIO continues to play an important role in facilitating the emergence of the biotech industry in China and we are committed to supporting our members鈥 efforts in this important market."

Three keynote speakers will provide insights on the business opportunities surrounding the biotech sector in China, including Gary F. Locke, Ambassador of the United States of America to the People鈥檚 Republic of China; Bian Zhenjia, Assistant Minister, China Food and Drug Administration; and Zhao Yajun, Director General, China Center for Pharmaceutical Exchange.

Attendees will also be invited to one-on-one dialogues with biopharma industry executives who will discuss recent company successes, what keeps company executives up at night, and where the industry鈥檚 leading companies are headed in 2014. Industry executives currently scheduled to participate in the candid question-and-answer style sessions include Merck KGaA global leads Susan Herbert, PhD, Head of Global Business Development & Strategy; and Annalisa Jenkins, MBBS, MRCP, Executive Vice President and Head of Global Research and Development. Additional one-on-one dialogues will be held with Yan Xijun, Chairman of the Board of Tianjin Tasly Group, Wang Xiaodong, PhD, Director and Investigator, National Institute of Biological Sciences, and Wang Yinxiang, PhD, CEO & CSO, Zhejiang Beta Pharma.

The BIO Convention in China is designed to help both US and Chinese companies capitalize on the many opportunities in China鈥檚 rapidly growing market. According to GlobalData, China鈥檚 prescription drug market is projected to grow at a 26% compound annual rate, reaching $315 billion in 2020. Last year, it was $48 billion.

Panel sessions will highlight the latest issues and trends related to doing business in China. Program topics include science-focused sessions such as vaccine development, China鈥檚 unmet medical needs and the research and development of orphan drugs to treat rare diseases in China, as well as business-focused sessions exploring China鈥檚 private health care industry, early-stage VC funding in China, and partnering models between Chinese and Western companies.

Event attendees will have the opportunity to connect with industry leaders through BIO鈥檚 One-on-One PartneringSystem. Featured at all of the BIO business development, partnering and investor meetings in North America, Europe and Asia, the system schedules 30-minute meetings in private rooms at the conference. This industry-specific, web-based interactive software enables participants to move efficiently from the identification of prospective partners and investors to discussion and negotiations. To learn more about the system, including its evolution, read here.

BIO brings to China more than 17 years of experience in organizing international conferences for the biotech industry, including the BIO International Convention 鈥 the global event for biotechnology. BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations.

About BIO
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world鈥檚 largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtechNOW, an online portal and monthly newsletter chronicling 鈥渋nnovations transforming our world.鈥 Subscribe to BIOtechNOW.

Upcoming BIO Events

Pacific Rim Summit on Industrial Biotechnology & Bioenergy
December 8-11, 2013
San Diego, CA

BIO CEO & Investor Conference
February 10 鈥 11, 2014
New York, NY

BIO Asia International Conference
April 8-9, 2014
Tokyo, Japan

World Congress on Industrial Biotechnology
May 12-15, 2014
Philadelphia, PA

BIO International Convention
June 23-26, 2014
San Diego, CA

Livestock Biotech Summit
September 16-18, 2014
Sioux Falls, SD

Contacts
Biotechnology Industry Organization

Contact in China:
Amber He, + 86 189 1042 0217
amber.he@cohnwolfe.com
or
Contact in U.S.:
Daniel Seaton, 1-202-470-5207
dseaton@bio.org
Web: www.bio.org
Blog: www.biotech-now.org
Twitter: @IAmBiotech

Related News>> more
advertisement

Copyright(C) 2006-2014 bio-equip    E-mail:web@bio-equip.cn   娌狪CP澶06040519鍙